Literature DB >> 31090886

Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction.

Masafumi Takae1, Eiichiro Yamamoto1, Takanori Tokitsu1, Fumi Oike1, Taiki Nishihara1, Koichiro Fujisue1, Daisuke Sueta1, Hiroki Usuku1, Kota Motozato1, Miwa Ito1, Hisanori Kanazawa1, Satoshi Araki1, Taishi Nakamura1, Yuichiro Arima1, Seiji Takashio1, Satoru Suzuki1, Kenji Sakamoto1, Hirofumi Soejima1, Hiroshige Yamabe1, Koichi Kaikita1, Kenichi Tsujita1.   

Abstract

BACKGROUND: Although pulse wave velocity (PWV) is recognized to be a risk predictor for various cardiovascular diseases, the association of brachial-ankle PWV (baPWV) with cardiovascular outcomes in heart failure (HF) with reduced ejection fraction (HFrEF) patients remains uncertain.
METHODS: We measured ankle-brachial pressure index (ABI) and baPWV values at stable condition after optimal therapy for HF in 201 consecutive HFrEF patients admitted to Kumamoto University Hospital from 2007 to 2015 who were enrolled and followed until the occurrence of cardiovascular events. We defined peripheral artery disease (PAD) as ABI value ≤ 0.9.
RESULTS: Kaplan-Meier analysis revealed that HFrEF patients with peripheral artery disease PAD had a significant higher risk of total cardiovascular and HF-related events than those without PAD (P = 0.03 and P = 0.01, respectively). Next, we divided HFrEF patients without PAD into 3 groups according to baPWV values. In the Kaplan-Meier analysis, total cardiovascular and HF-related events in the highest baPWV group (1,800 cm/second ≤ baPWV) had a significantly higher frequency than those in the mid-level baPWV group (1,400 cm/second ≤ baPWV < 1,800 cm/second) (P = 0.007 and P = 0.004, respectively). The hazard ratio between HFrEF patients in the mid-level baPWV group and those with other baPWV groups was compared after adjustment for other cofounders. The probabilities of HF-related events were significantly higher in the lowest and highest baPWV group.
CONCLUSION: Identifying complications of PAD and measuring baPWV values in HFrEF patients were useful for predicting their prognosis.Trial Registration: UMIN000034358. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; heart failure; hypertension; prognosis; pulse wave velocity; reduced ejection fraction

Year:  2019        PMID: 31090886     DOI: 10.1093/ajh/hpz048

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Clinical Applications Measuring Arterial Stiffness: An Expert Consensus for the Application of Cardio-Ankle Vascular Index.

Authors:  Matthew J Budoff; Bruce Alpert; Julio A Chirinos; Bo Fernhall; Naomi Hamburg; Kazuomi Kario; Iftikhar Kullo; Kunihiro Matsushita; Toru Miyoshi; Hirofumi Tanaka; Ray Townsend; Paul Valensi
Journal:  Am J Hypertens       Date:  2022-05-10       Impact factor: 3.080

Review 2.  State of the Art Review: Brachial-Ankle PWV.

Authors:  Hirofumi Tomiyama; Kazuki Shiina
Journal:  J Atheroscler Thromb       Date:  2020-05-23       Impact factor: 4.928

Review 3.  Cardiovascular Outcomes in the Acute Phase of COVID-19.

Authors:  Hiroki Nakano; Kazuki Shiina; Hirofumi Tomiyama
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

4.  Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure.

Authors:  Stathis Dimitropoulos; Vasiliki Chara Mystakidi; Evangelos Oikonomou; Gerasimos Siasos; Vasiliki Tsigkou; Dimitris Athanasiou; Nikolaos Gouliopoulos; Evanthia Bletsa; Aimilios Kalampogias; Georgios Charalambous; Costas Tsioufis; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

5.  Association of impaired arterial wall properties with the presence of coronary artery disease in patients with abdominal aortic aneurysms.

Authors:  Pinelopi Rafouli-Stergiou; Ignatios Ikonomidis; Niki Katsiki; Nikolaos P E Kadoglou; Stefanos Vlachos; John Thymis; John Parissis; Konstantinos G Moulakakis; John D Kakisis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.